Geneva Capital Management LLC Biolife Solutions Inc Transaction History

Geneva Capital Management LLC

$5.85 Billion
Q2 2025

A detailed history of Geneva Capital Management LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Geneva Capital Management LLC holds 901,764 shares of BLFS stock, worth $21.7 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

901,764

Previous 852,127 5.83%

Holding current value

$21.7 Million

Previous $19.5 Million 0.2%

% of portfolio

0.33%

Previous 0.37%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$20.64 - $25.27 $1.02 Million - $1.25 Million	49,637 Added 5.83%	901,764 $19.4 Million
Q1 2025 May 09, 2025	SELL	$22.84 - $28.49 $14,023 - $17,492	-614 Reduced 0.07%	852,127 $19.5 Million
Q4 2024 Feb 06, 2025	SELL	$20.47 - $27.47 $256,386 - $344,061	-12,525 Reduced 1.45%	852,741 $22.1 Million
Q3 2024 Nov 05, 2024	BUY	$19.19 - $26.52 $18,518 - $25,591	965 Added 0.11%	865,266 $21.7 Million
Q2 2024 Aug 14, 2024	BUY	$15.14 - $22.99 $13.1 Million - $19.9 Million	864,301 New	864,301 $18.5 Million
Q1 2024 May 03, 2024	BUY	$15.35 - $18.82 $87,955 - $107,838	5,730 Added 0.66%	880,215 $16.3 Million
Q4 2023 Feb 06, 2024	SELL	$8.99 - $16.86 $5.85 Million - $11 Million	-650,906 Reduced 42.67%	874,485 $14.2 Million
Q3 2023 Nov 13, 2023	SELL	$10.81 - $22.96 $389,722 - $827,753	-36,052 Reduced 2.31%	1,525,391 $21.1 Million
Q2 2023 Aug 01, 2023	BUY	$17.19 - $24.34 $47,272 - $66,935	2,750 Added 0.18%	1,561,443 $34.5 Million
Q1 2023 May 12, 2023	BUY	$17.67 - $26.07 $682,768 - $1.01 Million	38,640 Added 2.54%	1,558,693 $33.9 Million
Q4 2022 Feb 07, 2023	SELL	$16.95 - $25.07 $298,031 - $440,805	-17,583 Reduced 1.14%	1,520,053 $27.7 Million
Q3 2022 Nov 02, 2022	BUY	$14.64 - $26.7 $22.5 Million - $41.1 Million	1,537,636 New	1,537,636 $35 Million
Q2 2022 Aug 02, 2022	SELL	$10.54 - $24.2 $36,415 - $83,611	-3,455 Reduced 0.24%	1,453,201 $20.1 Million
Q1 2022 May 02, 2022	SELL	$20.81 - $37.29 $673,161 - $1.21 Million	-32,348 Reduced 2.17%	1,456,656 $33.1 Million
Q4 2021 Feb 02, 2022	BUY	$32.99 - $58.55 $5.87 Million - $10.4 Million	177,875 Added 13.57%	1,489,004 $55.5 Million
Q3 2021 Nov 08, 2021	BUY	$42.03 - $60.5 $12 Million - $17.2 Million	284,432 Added 27.7%	1,311,129 $55.5 Million
Q2 2021 Aug 11, 2021	SELL	$29.51 - $44.62 $188,804 - $285,478	-6,398 Reduced 0.62%	1,026,697 $45.7 Million
Q1 2021 May 03, 2021	BUY	$32.95 - $44.24 $34 Million - $45.7 Million	1,033,095 New	1,033,095 $37.2 Million

Others Institutions Holding BLFS

# of Institutions

205

Shares Held

50.5M

Call Options Held

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.03B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Capital Management LLC with notifications on news.

Account

Geneva Capital Management LLC Biolife Solutions Inc Transaction History